Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance.

about

The biology and role of CD44 in cancer progression: therapeutic implications.Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.A correlation study of the expression of HA-CD44st and HER-2 in breast cancer

P2860

Q54110894-EE6C5964-A2C4-4C95-B0C3-0ABD218167D7 Q55309145-6386E022-1934-40F6-8F09-6571FB5C4ABC Q58754066-B8CFFF76-1354-461F-9AE8-2126BAFBC43C

P2860

Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance.

Item

http://www.wikidata.org/entity/Q38845190

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Overexpression of Specific CD4 ...... Acquired Endocrine Resistance.

@en

type

Item

label

Overexpression of Specific CD4 ...... Acquired Endocrine Resistance.

@en

prefLabel

Overexpression of Specific CD4 ...... Acquired Endocrine Resistance.

@en

P1476

Overexpression of Specific CD4 ...... Acquired Endocrine Resistance.

@en

P2093

Chris Smith

http://www.w3.org/2001/XMLSchema#string

Julia Gee

http://www.w3.org/2001/XMLSchema#string

Peter Barrett-Lee

http://www.w3.org/2001/XMLSchema#string

Rebecca Bellerby

http://www.w3.org/2001/XMLSchema#string

Stephen Hiscox

http://www.w3.org/2001/XMLSchema#string

Sue Kyme

http://www.w3.org/2001/XMLSchema#string

Ursula Günthert

http://www.w3.org/2001/XMLSchema#string

P2860

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis

Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion

Differential effect of growth factors on invasion and proliferation of endocrine resistant breast cancer cells

CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance.

Estimation of prognostic value of CD44 expression in neuroblastic tumours in children.

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.

CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.

P304

145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2016.00145

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew R. Green

Emad A. Rakha

P577

2016-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27379207

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

4913094

http://www.w3.org/2001/XMLSchema#string

Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance.

about

P2860

P2860

Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932